| Dr Joel Michael Hartman, MD | |
|
1372 Westgate Center Dr, Winston Salem, NC 27103-2932 | |
| (336) 659-4814 | |
| (336) 768-4745 |
| Full Name | Dr Joel Michael Hartman |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 22 Years |
| Location | 1372 Westgate Center Dr, Winston Salem, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184606147 | NPI | - | NPPES |
| NC0853B | Other | NC | MEDICARE PTAN |
| 1184606147 | Medicaid | VA | |
| 1184606147 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 2005-01185 (North Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Partners Pllc | 7113822420 | 149 |
News Archive
EKOS Corporation announced today that they received a $2.7 million grant from the National Institutes of Health for the development of a product to provide therapy for intracerebral hemorrhagic stroke.
After 27 years at AARP, John Rother will move on to head up the National Coalition on Health Care. He says his new position will give him a platform to take on health care costs, as issue he views as central to the nation.
The phase 3 trials of the Pfizer and Moderna COVID-19 vaccines did not include those with a known previous SARS-CoV-2 infection. Recent evidence indicates that mRNA vaccines may induce more adverse events in these individuals. In a recent study, 947 individuals, 265 of which have previously reported SARS-CoV-2 infection, were monitored post-vaccination for adverse events, finding that there could be a link between previous infection and greater incidence of these events.
Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.
Imagine the benefits if there was technology that pinpointed exactly which chemotherapy drugs work best in fighting each individual's type of cancer. No more guessing. No more trial and error. The good news is that such lifesaving technology is on its way to becoming reality.
› Verified 5 days ago
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
EKOS Corporation announced today that they received a $2.7 million grant from the National Institutes of Health for the development of a product to provide therapy for intracerebral hemorrhagic stroke.
After 27 years at AARP, John Rother will move on to head up the National Coalition on Health Care. He says his new position will give him a platform to take on health care costs, as issue he views as central to the nation.
The phase 3 trials of the Pfizer and Moderna COVID-19 vaccines did not include those with a known previous SARS-CoV-2 infection. Recent evidence indicates that mRNA vaccines may induce more adverse events in these individuals. In a recent study, 947 individuals, 265 of which have previously reported SARS-CoV-2 infection, were monitored post-vaccination for adverse events, finding that there could be a link between previous infection and greater incidence of these events.
Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.
Imagine the benefits if there was technology that pinpointed exactly which chemotherapy drugs work best in fighting each individual's type of cancer. No more guessing. No more trial and error. The good news is that such lifesaving technology is on its way to becoming reality.
› Verified 5 days ago
| Entity Name | Allergy Partners Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205826559 PECOS PAC ID: 7113822420 Enrollment ID: O20040628000753 |
News Archive
EKOS Corporation announced today that they received a $2.7 million grant from the National Institutes of Health for the development of a product to provide therapy for intracerebral hemorrhagic stroke.
After 27 years at AARP, John Rother will move on to head up the National Coalition on Health Care. He says his new position will give him a platform to take on health care costs, as issue he views as central to the nation.
The phase 3 trials of the Pfizer and Moderna COVID-19 vaccines did not include those with a known previous SARS-CoV-2 infection. Recent evidence indicates that mRNA vaccines may induce more adverse events in these individuals. In a recent study, 947 individuals, 265 of which have previously reported SARS-CoV-2 infection, were monitored post-vaccination for adverse events, finding that there could be a link between previous infection and greater incidence of these events.
Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.
Imagine the benefits if there was technology that pinpointed exactly which chemotherapy drugs work best in fighting each individual's type of cancer. No more guessing. No more trial and error. The good news is that such lifesaving technology is on its way to becoming reality.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joel Michael Hartman, MD Po Box 603725, Charlotte, NC 28260-3725 Ph: (828) 575-2625 | Dr Joel Michael Hartman, MD 1372 Westgate Center Dr, Winston Salem, NC 27103-2932 Ph: (336) 659-4814 |
News Archive
EKOS Corporation announced today that they received a $2.7 million grant from the National Institutes of Health for the development of a product to provide therapy for intracerebral hemorrhagic stroke.
After 27 years at AARP, John Rother will move on to head up the National Coalition on Health Care. He says his new position will give him a platform to take on health care costs, as issue he views as central to the nation.
The phase 3 trials of the Pfizer and Moderna COVID-19 vaccines did not include those with a known previous SARS-CoV-2 infection. Recent evidence indicates that mRNA vaccines may induce more adverse events in these individuals. In a recent study, 947 individuals, 265 of which have previously reported SARS-CoV-2 infection, were monitored post-vaccination for adverse events, finding that there could be a link between previous infection and greater incidence of these events.
Current treatments for Lyme disease, particularly chronic forms of the disease, are inadequate, according to a new treatment guideline written by a group of leading experts.
Imagine the benefits if there was technology that pinpointed exactly which chemotherapy drugs work best in fighting each individual's type of cancer. No more guessing. No more trial and error. The good news is that such lifesaving technology is on its way to becoming reality.
› Verified 5 days ago
Dr. Robert Mitchell Ross, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1401 Old Mill Cir Ste A, Winston Salem, NC 27103 Phone: 336-768-0914 Fax: 336-760-1896 | |
Holly Murrell Mcpherson, M. D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1372 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-659-4814 Fax: 336-768-4745 | |
Ingrid Margarete Hoffmann, M. D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1372 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-659-4814 Fax: 336-768-4745 | |
Kent Joseph Nastasi, M. D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1372 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-659-4814 Fax: 336-768-4745 | |
Nicole Marie Lawing Koutlas, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 1372 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-659-4814 | |
Elizabeth Rose Scannell, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1372 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-659-4814 Fax: 336-768-4745 |